반응식
[CH3:1][O:2][C:3]1[CH:8]=[CH:7][C:6]([N:9]2[CH2:14][CH2:13][N:12]([CH2:15][C:16]3[C:17]([NH2:23])=[N:18][C:19]([NH2:22])=[N:20][CH:21]=3)[CH2:11][CH2:10]2)=[CH:5][CH:4]=1.[ClH:24]>CO>[ClH:24].[CH3:1][O:2][C:3]1[CH:4]=[CH:5][C:6]([N:9]2[CH2:10][CH2:11][N:12]([CH2:15][C:16]3[C:17]([NH2:23])=[N:18][C:19]([NH2:22])=[N:20][CH:21]=3)[CH2:13][CH2:14]2)=[CH:7][CH:8]=1참가 물질
4
실험 절차
0.23 g (0.00073 mol) of 5-[4-(4-methoxy-phenyl)-piperazin-1-ylmethyl]-pyrimidine-2,4-diamine was dissolved in 250 ml of hot methanol. The solution was treated at room temperature with 0.84 ml (0.00293 mol) of 3.5N ethanolic hydrochloric acid. The solution was completely freed from the solvents and recrystallized from methanol/diethyl ether. 0.27 g (96%) of 5-[4-(4-methoxy-phenyl)-piperazin-1-ylmethyl]-pyrimidine-2,4-diamine hydrochloride (1:2.3) was obtained as white crystals; m.p. 215°-216°.
후처리
- customrecrystallized from methanol/diethyl ether
출처 및 근거
- ORD 기록
- ord-c7d476bda2394c02a6f3f9a7f7daf958
- 출처 데이터셋
- uspto-grants-1997_11
- 특허 번호
- US05688798
연결된 노트
불러오는 중…